DUSP6 Deficiency Attenuates Neurodegeneration after Global Cerebral Ischemia

Yi-Chinn Weng1, Yu-Ting Huang1, I-Chen Chiang1

  • 1Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County 35053, Taiwan.

Insights

DUSP6 deficiency protects against neurodegeneration after transient global cerebral ischemia (tGCI) by enhancing Erk1/2 signaling. This suggests DUSP6 inhibition is a potential therapeutic strategy for tGCI-induced brain damage.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Pathology

Background:

  • Transient global cerebral ischemia (tGCI) causes selective CA1 hippocampal neuron death.
  • Erk1/2 phosphorylation promotes neuronal survival post-tGCI.
  • DUSP6 dephosphorylates Erk1/2, but its role in tGCI is unknown.

Purpose of the Study:

  • To investigate the role of DUSP6 in the neurodegeneration following tGCI.
  • To determine if DUSP6 deficiency impacts spatial memory and neuronal survival after tGCI.

Main Methods:

  • Induction of tGCI in wild-type and DUSP6-deficient mice.
  • Assessment of spatial memory using the Barnes maze.
  • Histological analysis (Fluoro-Jade C, H&E) for neurodegeneration.
  • Western blot analysis for Erk1/2 phosphorylation and nuclear translocation.

Main Results:

  • DUSP6 expression was induced in hippocampal CA1 neurons post-tGCI.
  • DUSP6-deficient mice exhibited attenuated spatial memory impairment after tGCI.
  • Neurodegeneration in the hippocampus was reduced in DUSP6-deficient mice.
  • DUSP6 deficiency enhanced Erk1/2 phosphorylation and nuclear translocation in CA1 neurons.

Conclusions:

  • DUSP6 acts as a negative regulator of Erk1/2 signaling in the context of tGCI.
  • DUSP6 deficiency confers neuroprotection against tGCI-induced damage.
  • Inhibiting DUSP6 may represent a novel therapeutic approach for tGCI.